Rankings
▼
Calendar
ELVN FY 2025 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ELVN
Enliven Therapeutics, Inc.
$2B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$263,000
Operating Income
-$120M
Net Income
-$104M
EPS (Diluted)
$-1.83
Cash Flow
Operating Cash Flow
-$70M
Free Cash Flow
-$70M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$476M
Total Liabilities
$17M
Stockholders' Equity
$460M
Cash & Equivalents
$99M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$263,000
$0
—
Operating Income
-$120M
-$105M
-14.4%
Net Income
-$104M
-$89M
-16.5%
← Q4 2024
All Quarters
Q1 2025 →